402 related articles for article (PubMed ID: 25912721)
1. Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages.
Lee WH; Loo CY; Traini D; Young PM
Expert Opin Drug Deliv; 2015 Jun; 12(6):1009-26. PubMed ID: 25912721
[TBL] [Abstract][Full Text] [Related]
2. Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcome.
Patel B; Gupta N; Ahsan F
Eur J Pharm Biopharm; 2015 Jan; 89():163-74. PubMed ID: 25497488
[TBL] [Abstract][Full Text] [Related]
3. Distribution and Cellular Uptake of PEGylated Polymeric Particles in the Lung Towards Cell-Specific Targeted Delivery.
Shen TW; Fromen CA; Kai MP; Luft JC; Rahhal TB; Robbins GR; DeSimone JM
Pharm Res; 2015 Oct; 32(10):3248-60. PubMed ID: 26002743
[TBL] [Abstract][Full Text] [Related]
4. Update on macrophage clearance of inhaled micro- and nanoparticles.
Geiser M
J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):207-17. PubMed ID: 20109124
[TBL] [Abstract][Full Text] [Related]
5. Interactions with the macrophages: An emerging targeted approach using novel drug delivery systems in respiratory diseases.
Mehta M; Deeksha ; Sharma N; Vyas M; Khurana N; Maurya PK; Singh H; Andreoli de Jesus TP; Dureja H; Chellappan DK; Gupta G; Wadhwa R; Collet T; Hansbro PM; Dua K; Satija S
Chem Biol Interact; 2019 May; 304():10-19. PubMed ID: 30849336
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary delivery of anti-inflammatory agents.
Ali ME; McConville JT; Lamprecht A
Expert Opin Drug Deliv; 2015 Jun; 12(6):929-45. PubMed ID: 25534260
[TBL] [Abstract][Full Text] [Related]
7. Micro- and nanocarrier-mediated lung targeting.
Kurmi BD; Kayat J; Gajbhiye V; Tekade RK; Jain NK
Expert Opin Drug Deliv; 2010 Jul; 7(7):781-94. PubMed ID: 20560777
[TBL] [Abstract][Full Text] [Related]
8. Targeted drug delivery to macrophages.
Jain NK; Mishra V; Mehra NK
Expert Opin Drug Deliv; 2013 Mar; 10(3):353-67. PubMed ID: 23289618
[TBL] [Abstract][Full Text] [Related]
9. Macrophage targeted nanocarrier delivery systems in HIV therapeutics.
Khan T; Mayuresh Patkar M; Momin M; Omri A
Expert Opin Drug Deliv; 2020 Jul; 17(7):903-918. PubMed ID: 32347124
[TBL] [Abstract][Full Text] [Related]
10. In-vitro and in-vivo characterization of a multi-stage enzyme-responsive nanoparticle-in-microgel pulmonary drug delivery system.
Mejías JC; Roy K
J Control Release; 2019 Dec; 316():393-403. PubMed ID: 31715279
[TBL] [Abstract][Full Text] [Related]
11. Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives.
Iyer R; Hsia CC; Nguyen KT
Curr Pharm Des; 2015; 21(36):5233-44. PubMed ID: 26412358
[TBL] [Abstract][Full Text] [Related]
12. Development of Dried Emulsion/Mannitol Composite Microparticles through a Unique Spray Nozzle for Efficient Delivery of Hydrophilic Anti-tuberculosis Drug against Alveolar Macrophages.
Maeda R; Ito T; Tagami T; Takii T; Ozeki T
Biol Pharm Bull; 2019; 42(11):1846-1853. PubMed ID: 31685768
[TBL] [Abstract][Full Text] [Related]
13. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.
Sayes CM; Reed KL; Warheit DB
Toxicol Sci; 2007 May; 97(1):163-80. PubMed ID: 17301066
[TBL] [Abstract][Full Text] [Related]
14. Liposome-based drug delivery to alveolar macrophages.
Vyas SP; Khatri K
Expert Opin Drug Deliv; 2007 Mar; 4(2):95-9. PubMed ID: 17335407
[TBL] [Abstract][Full Text] [Related]
15. Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages.
Vyas SP; Quraishi S; Gupta S; Jaganathan KS
Int J Pharm; 2005 May; 296(1-2):12-25. PubMed ID: 15885451
[TBL] [Abstract][Full Text] [Related]
16. General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.
Wakaskar RR
J Drug Target; 2018 Apr; 26(4):311-318. PubMed ID: 28797169
[TBL] [Abstract][Full Text] [Related]
17. Targeting of Hepatic Macrophages by Therapeutic Nanoparticles.
Colino CI; Lanao JM; Gutierrez-Millan C
Front Immunol; 2020; 11():218. PubMed ID: 32194546
[TBL] [Abstract][Full Text] [Related]
18. Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes.
Chono S; Tanino T; Seki T; Morimoto K
J Drug Target; 2006 Sep; 14(8):557-66. PubMed ID: 17043040
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
Gaumet M; Vargas A; Gurny R; Delie F
Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
[TBL] [Abstract][Full Text] [Related]
20. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
